PARP inhibitors: Halting cancer by halting DNA repair

Over 30,000 people worldwide have been treated with PARP inhibitors for various cancers. The development of these drugs is a fascinating story of CRUK-funded collaborative research between scientists and physicians to discover how blocking DNA repair could target cancer cells. Read the story here